Table 2 Laboratory results, symptoms, diagnoses, and interventions during hospitalization among hospitalized COVID-19 patients, overall and by outcome

Duration of Hospitalization (median, IQR)

6.0

(4, 11)

11.0

(6, 19)

15.0

(8, 24)

10.0

(5, 17)

Observations (median, IQR)

 Temperature, °C

36.8

(36.5, 37.1)

36.8

(36.5, 37.2)

36.8

(36.5, 37.3)

36.8

(36.4, 37.4)

  > 38

3,609

6.6

971

8.3

929

10.4

981

11.9

 Oxygen saturation (SpO₂), %

95.0

(93.0, 97.3)

95.0

(92.0, 97.2)

95.0

(92.0, 97.4)

95.0

(91.0, 97.0)

  < 90

2457

10.1

1193

14.9

1107

14.7

1051

17.6

 Platelet count × 10⁹ per L

224.0

(169.0, 298.0)

228.0

(165.0, 309.0)

225.0

(161.0, 306.0)

200.0

(143.0, 271.0)

  < 150

9355

17.0

2324

19.7

1,879

20.8

2334

28.1

 C-reactive protein, mg/L

60.5

(21.1, 124.0)

86.3

(34.1, 163.0)

97.7

(40.3, 178.0)

107.9

(51.0, 181.3)

  > 10

30,979

85.7

8353

90.5

6469

92.1

5773

94.1

 Ferritin, ng/mL

478.0

(219.1, 942.0)

632.0

(309.0, 1175.5)

673.1

(338.0, 1284.7)

689.0

(339.1, 1309.9)

  > 300

22,216

66.3

6371

75.6

5141

78.0

4394

78.3

 Lactate dehydrogenase, U/L

310.0

(232.0, 428.0)

377.0

(277.0, 526.0)

406.0

(294.0, 566.0)

405.0

(285.0, 571.0)

  > 280

19,726

58.9

6235

73.9

5266

78.4

4384

75.8

 D-Dimer, ng/mL

465.0

(264.0, 880.0)

680.0

(376.5, 1345.0)

773.8

(429.5, 1616.0)

855.0

(480.0, 1695.0)

  > 250

19,021

76.8

5024

87.2

4006

89.7

3587

92.5

 Fibrinogen, mg/dL

529.0

(403.0, 667.0)

546.0

(400.0, 700.0)

557.0

(403.0, 700.0)

537.0

(394.0, 693.0)

  > 400

12,116

75.5

3750

74.9

3309

75.2

2501

74.2

Symptoms

 Hypoxemia

14,718

25.8

3968

33.2

3231

35.4

2719

31.9

 Fever

9158

16.1

2617

21.9

2035

22.3

1641

19.2

 Cough

7182

12.6

1656

13.8

1266

13.9

1032

12.1

 Nausea/Vomiting

3711

6.5

814

6.8

547

6.0

345

4.0

 Malaise and fatigue

7483

13.1

2242

18.7

1723

18.9

1484

17.4

 Dyspnea or shortness of breath

15,979

28.0

4472

37.4

3781

41.4

2971

34.8

Diagnoses

 Acute respiratory failure

25,525

44.8

9472

79.2

7825

85.7

6187

72.6

 Pneumonia

33,946

59.6

9771

81.6

7738

84.7

6565

77.0

 Sepsis

12,646

22.2

5812

48.6

4995

54.7

4168

48.9

 Coagulation defects or hemorrhagic conditions

3490

6.1

1715

14.3

1456

15.9

1101

12.9

 Arrhythmia

4799

8.4

2112

17.6

1772

19.4

1439

16.9

 Heart failure

7934

13.9

2775

23.2

2380

26.1

2441

28.6

 MI

3437

6.0

1535

12.8

1293

14.2

1251

14.7

 Kidney disease*

17,694

31.0

6103

51.0

5110

55.9

5257

61.7

 Liver disease

2671

4.7

985

8.2

830

9.1

681

8.0

Treatments

 Chloroquine/Hydroxychloroquine

8852

15.5

2805

23.4

2632

28.8

2084

24.4

 Lopinavir/Ritonavir

427

0.7

205

1.7

181

2.0

166

1.9

 Remdesivir

12,990

22.8

3274

27.4

2829

31.0

1901

22.3

 Dexamethasone

16,698

29.3

3968

33.2

3582

39.2

2520

29.6

 ACEs/ARBs

12,313

21.6

2492

20.8

2112

23.1

1546

18.1

 Anticoagulants

45,509

79.8

10,569

88.3

8286

90.7

7362

86.3

 Immunosuppressants

3009

5.3

1409

11.8

1344

14.7

799

9.4

 Antibacterials for systemic use

38,050

66.8

9373

78.3

7927

86.8

6967

81.7

 Antivirals for systemic use

1847

3.2

633

5.3

555

6.1

434

5.1

 Corticosteroids for systemic use

26,615

46.7

6897

57.6

6320

69.2

4699

55.1